📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Unanchored simulated treatment comparison on survival outcomes using parametric and Royston-Parmar models with application to lenvatinib plus pembrolizumab in renal cell carcinoma. (2025)

First Author: Fawsitt CG

Attributed to: What is the value of adaptive designs? Estimating expected value of sample information for adaptive trial designs. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s12874-025-02480-x

PubMed Identifier: 39885377

Publication URI: http://europepmc.org/abstract/MED/39885377

Type: Journal Article/Review

Volume: 25

Parent Publication: BMC medical research methodology

Issue: 1

ISSN: 1471-2288